Disorders of plasma sodium-causes, consequences, and correction

New England Journal of Medicine

Volumn 372, Issue 1, 2015, Pages 55-65

  Sterns, Richard H ^a  

^a UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); DESMOPRESSIN; FUROSEMIDE; GLUCOSE; HYPERTONIC SOLUTION; POTASSIUM; SODIUM; SODIUM CHLORIDE; UREA; VANILLOID RECEPTOR 1; VANILLOID RECEPTOR 4; VASOPRESSIN; VASOPRESSIN ANTAGONIST;

ACUTE SALT POISONING; ADIPSIA; BLOOD BRAIN BARRIER; BRAIN EDEMA; BRAIN HEMORRHAGE; BRAIN INJURY; CATION EXCHANGE; CHANNEL GATING; CONCEPTUAL FRAMEWORK; DEMYELINATION; DIABETES INSIPIDUS; DISEASE SEVERITY; DRUG CONTRAINDICATION; DRUG INDICATION; GLUCOSURIA; HEMODIALYSIS; HUMAN; HYPERNATREMIA; HYPEROSMOTIC STRESS; HYPONATREMIA; HYPOOSMOTIC STRESS; INFANTILE DIARRHEA; INTOXICATION; INTRACRANIAL HYPERTENSION; MATHEMATICAL COMPUTING; MATHEMATICAL MODEL; MENTAL DISEASE; NEPHROGENIC DIABETES INSIPIDUS; NEUROGENIC DIABETES INSIPIDUS; OSMORECEPTOR; OSMOREGULATION; OSMOSIS; OSMOTIC DEMYELINATION SYNDROME; OSMOTIC DIURESIS; PATIENT MONITORING; POSTOPERATIVE COMPLICATION; POSTOPERATIVE HYPONATREMIA; POTASSIUM BALANCE; PROTEIN EXPRESSION; PROTEIN FUNCTION; REHYDRATION; REVIEW; SEIZURE; SODIUM BALANCE; SODIUM BLOOD LEVEL; SODIUM CELL LEVEL; SODIUM EXCRETION; SODIUM RESTRICTION; SODIUM TRANSPORT; SODIUM URINE LEVEL; SUBSTITUTION THERAPY; SUICIDE ATTEMPT; THIRST; TOTAL BODY WATER; VASOPRESSIN RELEASE; WATER DEPRIVATION; WATER INTOXICATION; WATER LOSS; WATER TRANSPORT; BLOOD; BRAIN DISEASES; CHEMISTRY; COMPLICATION; DEMYELINATING DISEASES; METABOLIC DISORDER; METABOLISM; PLASMA; URINE;

BRAIN DISEASES; BRAIN EDEMA; DEMYELINATING DISEASES; HUMANS; HYPERNATREMIA; HYPONATREMIA; PLASMA; SALINE SOLUTION, HYPERTONIC; SODIUM; WATER-ELECTROLYTE IMBALANCE;

EID: 84920405762     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMra1404489     Document Type: Review

References (79)

1. Bhave G, Neilson EG. Body fluid dynamics: back to the future. J Am Soc Nephrol 2011;22:2166-81.
2. Day RE, Kitchen P, Owen DS, et al. Human aquaporins: regulators of trans-cellular water f low. Biochim Biophys Acta 2014;1840:1492-506.
3. Edelman IS, Leibman J, O'Meara MP, Birkenfeld LW. Interrelations between serum sodium concentration, serum osmo-larity and total exchangeable sodium, total exchangeable potassium and total body water. J Clin Invest 1958; 37: 1236-56.
4. Nguyen MK, Kurtz I. Reply to: We-schler LB. The Edelman equation as it applies to acute and chronic hyponatremia. Am J Physiol Regul Integr Comp Physiol 2012;302:R899-R901.
5. Urban JP. The chondrocyte: a cell under pressure. Br J Rheumatol 1994; 33: 901-8.
6. Cannon WB. Organization for physiological homeostasis. Physiol Rev 1929; 9: 399-431.
7. Forbes GB, Tobin RB, Harrison A, McCoord A. Effect of acute hypernatre-mia, hyponatremia, and acidosis on bone sodium. Am J Physiol 1965; 209: 825-9.
8. Stormont JM, Waterhouse C. The genesis of hyponatremia associated with marked overhydration and water intoxication. Circulation 1961;24:191-203.
9. Farber SJ. Mucopolysaccharides and sodium metabolism. Circulation 1960; 21: 941-7.
10. Wynn V. The osmotic behaviour of the body cells in man; significance of changes of plasma-electrolyte levels in body-fluid disorders. Lancet 1957; 273: 1212-8.
11. Titze J, Dahlmann A, Lerchl K, et al. Spooky sodium balance. Kidney Int 2014; 85:759-67.
12. Heer M, Baisch F, Kropp J, Gerzer R, Drummer C. High dietary sodium chloride consumption may not induce body fluid retention in humans. Am J Physiol Renal Physiol 2000;278:F585-F595.
13. Noakes TD, Sharwood K, Speedy D, et al. Three independent biological mechanisms cause exercise-associated hypona-tremia: evidence from 2, 135 weighed competitive athletic performances. Proc Natl Acad Sci USA 2005; 102: 18550-5.
14. Titze J, Lang R, Ilies C, et al. Osmoti-cally inactive skin Na+ storage in rats. Am J Physiol Renal Physiol 2003; 285: F1108-F1117.
15. Titze J, Shakibaei M, Schafflhuber M, et al. Glycosaminoglycan polymerization may enable osmotically inactive Na+ storage in the skin. Am J Physiol Heart Circ Physiol 2004;287:H203-H208.
16. Wiig H, Schröder A, Neuhofer W, et al. Immune cells control skin lymphatic electrolyte homeostasis and blood pressure. J Clin Invest 2013; 123: 2803-15.
17. Hannon MJ, Verbalis JG. Sodium ho-meostasis and bone. Curr Opin Nephrol Hypertens 2014;23:370-6.
18. Hew-Butler T, Stuempfle KJ, Hoffman MD. Bone: an acute buffer of plasma sodium during exhaustive exercise? Horm Metab Res 2013;45:697-700.
19. Rose BD. New approach to disturbances in the plasma sodium concentration. Am J Med 1986; 81: 1033-40.
20. Berl T. Impact of solute intake on urine flow and water excretion. J Am Soc Nephrol 2008;19:1076-8.
21. Popli S, Tzamaloukas AH, Ing TS. Osmotic diuresis-induced hypernatremia: better explained by solute-free water clearance or electrolyte-free water clearance? Int Urol Nephrol 2014; 46: 207-10.
22. Lindner G, Schwarz C, Funk GC. Osmotic diuresis due to urea as the cause of hypernatraemia in critically ill patients. Nephrol Dial Transplant 2012; 27: 962-7.
23. Decaux G, Andres C, Gankam Kengne F, Soupart A. Treatment of euvolemic hy-ponatremia in the intensive care unit by urea. Crit Care 2010; 14: R184.
24. Soupart A, Coffernils M, Couturier B, Gankam-Kengne F, Decaux G. Efficacy and tolerance of urea compared with vap-tans for long-term treatment of patients with SIADH. Clin J Am Soc Nephrol 2012; 7:742-7.
25. Levick JR, Michel CC. Microvascular fluid exchange and the revised Starling principle. Cardiovasc Res 2010; 87: 198-210.
26. Abbott NJ, Friedman A. Overview and introduction: the blood-brain barrier in health and disease. Epilepsia 2012; 53: Suppl 6:1-6.
27. Bichet DG. Physiopathology of hereditary polyuric states: a molecular view of renal function. Swiss Med Wkly 2012; 142: w13613.
28. Bourque CW. Central mechanisms of osmosensation and systemic osmoregula-tion. Nat Rev Neurosci 2008; 9: 519-31.
29. Sladek CD, Johnson AK. Integration of thermal and osmotic regulation of water homeostasis: the role of TRPV channels. Am J Physiol Regul Integr Comp Physiol 2013;305:R669-R678.
30. Tian W, Fu Y, Garcia-Elias A, et al. A loss-of-function nonsynonymous polymorphism in the osmoregulatory TRPV4 gene is associated with human hypona-tremia. Proc Natl Acad Sci USA 2009; 106:14034-9.
31. Zhang Z, Duckart J, Slatore CG, et al. Individuality of the plasma sodium concentration. Am J Physiol Renal Physiol 2014; 306: F1534-F1543.
32. Balanescu S, Kopp P, Gaskill MB, Morgenthaler NG, Schindler C, Ru-tishauser J. Correlation of plasma co-peptin and vasopressin concentrations in hypo-, iso-, and hyperosmolar states. J Clin Endocrinol Metab 2011; 96: 1046-52.
33. Antunes-Rodrigues J, de Castro M, Elias LL, Valença MM, McCann SM. Neu-roendocrine control of body fluid metabolism. Physiol Rev 2004; 84: 169-208.
34. Ellison DH, Berl T. The syndrome of inappropriate antidiuresis. N Engl J Med 2007;356:2064-72.
35. Adrogué HJ, Madias NE. Hypernatre-mia. N Engl J Med 2000; 342: 1493-9.
36. Atsariyasing W, Goldman MB. A systematic review of the ability of urine concentration to distinguish antipsychotic-from psychosis-induced hyponatremia. Psychiatry Res 2014;217:129-33.
37. Bhattarai N, Kafle P, Panda M. Beer potomania: a case report. BMJ Case Rep 2010. DOI: 10.1136/bcr.10.2009.2414.
38. Hix JK, Silver S, Sterns RH. Diuretic-associated hyponatremia. Semin Nephrol 2011;31:553-66.
39. Sterns RH, Nigwekar SU, Hix JK. The treatment of hyponatremia. Semin Nephrol 2009;29:282-99.
40. Adrogué HJ, Madias NE. The challenge of hyponatremia. J Am Soc Nephrol 2012;23:1140-8.
41. Vandergheynst F, Brachet C, Hein-richs C, Decaux G. Long-term treatment of hyponatremic patients with nephro-genic syndrome of inappropriate antidi-uresis: personal experience and review of published case reports. Nephron Clin Pract 2012;120:c168-c172.
42. Perianayagam A, Sterns RH, Silver SM, et al. DDAVP is effective in preventing and reversing inadvertent overcorrection of hyponatremia. Clin J Am Soc Nephrol 2008; 3: 331-6.
43. Mohmand HK, Issa D, Ahmad Z, Cap-puccio JD, Kouides RW, Sterns RH. Hy-pertonic saline for hyponatremia: risk of inadvertent overcorrection. Clin J Am Soc Nephrol 2007;2:1110-7.
44. Lehrich RW, Ortiz-Melo DI, Patel MB, Greenberg A. Role of vaptans in the management of hyponatremia. Am J Kidney Dis 2013;62:364-76.
45. Fenske W, Allolio B. The syndrome of inappropriate secretion of antidiuretic hormone: diagnostic and therapeutic advances. Horm Metab Res 2010; 42: 691-702.
46. Fenske W, Maier SK, Blechschmidt A, Allolio B, Störk S. Utility and limitations of the traditional diagnostic approach to hyponatremia: a diagnostic study. Am J Med 2010; 123: 652-7.
47. Erratum, Am J Med 2011;124(10):e9.
48. Leaf A, Bartter FC, Santos RF, Wrong O. Evidence in man that urinary electrolyte loss induced by pitressin is a function of water retention. J Clin Invest 1953; 32: 868-78.
49. Steele A, Gowrishankar M, Abraham-son S, Mazer CD, Feldman RD, Halperin ML. Postoperative hyponatremia despite near-isotonic saline infusion: a phenomenon of desalination. Ann Intern Med 1997;126:20-5.
50. Hannon MJ, Behan LA, O'Brien MM, et al. Hyponatremia following mild/moderate subarachnoid hemorrhage is due to SIAD and glucocorticoid deficiency and not cerebral salt wasting. J Clin Endocri-nol Metab 2014;99:291-8.
51. Sterns RH, Silver SM. Cerebral salt wasting versus SIADH: what difference? J Am Soc Nephrol 2008; 19: 194-6.
52. Sterns RH, Silver SM. Salt and water: read the package insert. QJM 2003; 96: 549-52.
53. Burg MB, Ferraris JD, Dmitrieva NI. Cellular response to hyperosmotic stresses. Physiol Rev 2007; 87: 1441-74.
54. Strange K. Cellular volume homeosta-sis. Adv Physiol Educ 2004; 28: 155-9.
55. Yancey PH. Organic osmolytes as compatible, metabolic and counteracting cyto-protectants in high osmolarity and other stresses. J Exp Biol 2005; 208: 2819-30.
56. Verbalis JG. Brain volume regulation in response to changes in osmolality. Neuroscience 2010; 168: 862-70.
57. Pasantes-Morales H, Cruz-Rangel S. Brain volume regulation: osmolytes and aquaporin perspectives. Neuroscience 2010;168:871-84.
58. Gankam Kengne F, Nicaise C, Soupart A, et al. Astrocytes are an early target in osmotic demyelination syndrome. J Am Soc Nephrol 2011;22:1834-45.
59. Silver SM, Schroeder BM, Sterns RH, Rojiani AM. Myoinositol administration improves survival and reduces myelinoly-sis after rapid correction of chronic hypo-natremia in rats. J Neuropathol Exp Neu-rol 2006;65:37-44.
60. Gankam Kengne F, Soupart A, Pochet R, Brion JP, Decaux G. Re-induction of hyponatremia after rapid overcorrection of hyponatremia reduces mortality in rats. Kidney Int 2009; 76: 614-21.
61. Takagi H, Sugimura Y, Suzuki H, et al. Minocycline prevents osmotic demye-lination associated with aquaresis. Kidney Int 2014;86:954-64.
62. Sterns RH, Riggs JE, Schochet SS Jr. Osmotic demyelination syndrome following correction of hyponatremia. N Engl J Med 1986; 314: 1535-42.
63. de Souza A, Desai PK. More often striatal myelinolysis than pontine? A consecutive series of patients with osmotic demyelination syndrome. Neurol Res 2012;34:262-71.
64. Louis G, Megarbane B, Lavoué S, et al. Long-term outcome of patients hospitalized in intensive care units with central or extrapontine myelinolysis. Crit Care Med 2012;40:970-2.
65. Ismail FY, Szóllics A, Szólics M, Nagelkerke N, Ljubisavljevic M. Clinical semiology and neuroradiologic correlates of acute hypernatremic osmotic challenge in adults: a literature review. AJNR Am J Neuroradiol 2013;34:2225-32.
66. Soupart A, Penninckx R, Namias B, Stenuit A, Perier O, Decaux G. Brain my-elinolysis following hypernatremia in rats. J Neuropathol Exp Neurol 1996; 55: 106-13.
67. Bolat F, Oflaz MB, Güven AS, et al. What is the safe approach for neonatal hypernatremic dehydration? A retrospective study from a neonatal intensive care unit. Pediatr Emerg Care 2013; 29: 808-13.
68. Lee JH, Arcinue E, Ross BD. Organic osmolytes in the brain of an infant with hypernatremia. N Engl J Med 1994; 331: 439-42.
69. Corona G, Giuliani C, Parenti G, et al. Moderate hyponatremia is associated with increased risk of mortality: evidence from a meta-analysis. PLoS One 2013; 8(12):e80451.
70. Chawla A, Sterns RH, Nigwekar SU, Cappuccio JD. Mortality and serum sodium: do patients die from or with hypona-tremia? Clin J Am Soc Nephrol 2011; 6: 960-5.
71. Waikar SS, Mount DB, Curhan GC. Mortality after hospitalization with mild, moderate, and severe hyponatremia. Am J Med 2009;122:857-65.
72. Barsony J, Manigrasso MB, Xu Q, Tam H, Verbalis JG. Chronic hyponatremia exacerbates multiple manifestations of senescence in male rats. Age (Dordr) 2013; 35:271-88.
73. Bhaskar E, Kumar B, Ramalakshmi S. Evaluation of a protocol for hypertonic saline administration in acute euvolemic symptomatic hyponatremia: a prospective observational trial. Indian J Crit Care Med 2010;14:170-4.
74. Sood L, Sterns RH, Hix JK, Silver SM, Chen L. Hypertonic saline and desmo-pressin: a simple strategy for safe correction of severe hyponatremia. Am J Kidney Dis 2013;61:571-8.
75. Spasovski G, Vanholder R, Allolio B, et al. Clinical practice guideline on diagnosis and treatment of hyponatraemia. Nephrol Dial Transplant 2014; 29: Suppl 2: i1-i39.
76. Verbalis JG, Goldsmith SR, Greenberg A, et al. Diagnosis, evaluation, and treatment of hyponatremia: expert panel recommendations. Am J Med 2013; 126: Suppl 1:S1-S 42.
77. Carlberg DJ, Borek HA, Syverud SA, Holstege CP. Survival of acute hypernatre-mia due to massive soy sauce ingestion. J Emerg Med 2013; 45: 228-31.
78. Alshayeb HM, Showkat A, Babar F, Mangold T, Wall BM. Severe hypernatre-mia correction rate and mortality in hospitalized patients. Am J Med Sci 2011; 341: 356-60.
79. Bataille S, Baralla C, Torro D, et al. Undercorrection of hypernatremia is frequent and associated with mortality. BMC Nephrol 2014;15:3710.1186/1471-2369-15-37.